文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

乌司他丁通过减轻TLR4/NF-κB通路激活和减少炎症介质对LPS诱导急性肺损伤发挥保护作用

Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
PubMed 文献 · Shock · 2018-01-01
一句话结论动物与细胞实验显示乌司他丁可减轻LPS诱导的急性肺损伤,机制与减弱TLR4/NF-κB通路激活及减少炎症介质有关。

该研究探讨乌司他丁是否通过减弱TLR4表达减轻急性肺损伤并探索分子机制。雄性C56BL/6小鼠在气管内滴注LPS前1小时和暴露后6小时静脉给予乌司他丁,人肺上皮BEAS-2B细胞在有无乌司他丁时与LPS共孵育。乌司他丁显著减轻LPS诱导的急性肺损伤,降低肺湿/干重比、ALI评分、总细胞、中性粒细胞、巨噬细胞、髓过氧化物酶活性和丙二醛含量,并明显减弱TLR4及促炎细胞因子水平,显著减弱LPS诱导的肺组织TLR4蛋白表达和NF-κB活化增加;在LPS刺激的BEAS-2B细胞中同样明显减弱TLR4表达和NF-κB活化。

要点

  • 乌司他丁显著减轻LPS诱导的急性肺损伤,降低肺湿/干重比、ALI评分、总细胞、中性粒细胞、巨噬细胞、髓过氧化物酶活性和丙二醛含量。
  • 乌司他丁明显减弱TLR4及其他促炎细胞因子水平,并显著减弱LPS诱导的肺组织TLR4蛋白表达和NF-κB活化增加。
  • 在LPS刺激的BEAS-2B人肺上皮细胞中,乌司他丁同样明显减弱TLR4表达和NF-κB活化。
  • 作者结论:乌司他丁通过减弱TLR4/NF-κB通路激活改善LPS诱导的急性肺损伤。

适用人群与场景

  • 雄性C56BL/6小鼠,气管内滴注LPS诱导急性肺损伤模型。
  • 人肺上皮BEAS-2B细胞,LPS刺激模型。

处置流程与药物剂量

  • 雄性C56BL/6小鼠在气管内滴注LPS前1小时和暴露后6小时静脉给予乌司他丁。
  • BEAS-2B细胞在有无乌司他丁的条件下与LPS共孵育。

研究设计与关键结果

  • 动物实验:乌司他丁显著保护动物免受LPS诱导的急性肺损伤,降低肺湿/干重比、ALI评分、总细胞、中性粒细胞、巨噬细胞、髓过氧化物酶活性和丙二醛含量。
  • 乌司他丁明显减弱TLR4及其他促炎细胞因子水平,并显著减弱LPS诱导的肺组织TLR4蛋白表达和NF-κB活化增加。
  • 细胞实验:在LPS刺激的BEAS-2B细胞中,乌司他丁明显减弱TLR4表达和NF-κB活化。

证据类型、等级与局限

  • 证据类型:动物实验与体外细胞实验。
  • 作者结论:乌司他丁通过减弱TLR4/NF-κB通路激活改善LPS诱导的急性肺损伤。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome, remain the leading causes of morbidity and mortality in intensive care units. Ulinastatin (UTI), a serine protease inhibitor, possesses anti-inflammatory properties and has been suggested to modulate lipopolysaccharide (LPS)-induced sepsis; thus, it is now widely used in the treatment of pancreatitis, sepsis, and septic shock. Toll-like receptor 4 (TLR4), an essential LPS signaling receptor, plays a critical role in the activation of innate immunity. The aim of this study was to investigate whether UTI alleviates ALI by attenuating TLR4 expression and to explore the underlying molecular mechanisms involved. Male C56BL/6 mice were administered UTI intravenously 1 h before and 6 h after exposure to LPS by intratracheal instillation. Human lung epithelial (BEAS-2B) cells were incubated with LPS in the presence or absence of UTI. An enzyme-linked immunosorbent assay was used to detect levels of inflammatory cytokines. Western blot analysis was performed to detect changes in TLR4 expression and nuclear factor-κB (NF-κB) activation. UTI significantly protected animals from LPS-induced ALI, decreasing the lung wet/dry weight ratio, ALI score, total cells, neutrophils, macrophages, myeloperoxidase activity, and malondialdehyde content, factors associated with lung histological damage. UTI treatment also markedly attenuated levels of TLR4 and other proinflammatory cytokines. Furthermore, UTI significantly attenuated LPS-induced increases in TLR4 protein expression and NF-κB activation in lung tissues. Similarly, UTI markedly attenuated TLR4 expression and NF-κB activation in LPS-stimulated BEAS-2B cells. These findings indicate that UTI ameliorates LPS-induced ALI by attenuating the TLR4/NF-κB pathway activation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Cao C, Yin C, Shou S, et al. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators. Shock. 2018. PMID: 29324628. doi:10.1097/SHK.0000000000001104

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。